Cargando…
Development of a Chemiluminescence Immunoassay for Serum YB-1 and its Clinical Application as a Potential Diagnostic Marker for Hepatocellular Carcinoma
BACKGROUND: Y-box binding protein 1 (YB-1) overexpression has been shown in various tumor cells including hepatocellular carcinoma (HCC); moreover, this protein can be actively secreted. OBJECTIVES: The aim of this study was to establish a method to quantify serum YB-1 and evaluate its clinical appl...
Autores principales: | Pu, Li, Jing, Shi, Bianqin, Guo, Ping, Liu, Qindong, Liang, Chenggui, Liu, Feng, Cheng, Wenbin, Kuang, Qin, Wang, Jinyu, Dong, Qianfeng, Xia, Yu, Liu, Zhiguang, Tu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782250/ https://www.ncbi.nlm.nih.gov/pubmed/24069038 http://dx.doi.org/10.5812/hepatmon.8918 |
Ejemplares similares
-
The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies
por: Hou, Xiuzhu, et al.
Publicado: (2020) -
Clinical diagnostic performance of light‐initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody
por: Yang, Shuo, et al.
Publicado: (2019) -
Chemiluminescence enzyme immunoassay based on magnetic nanoparticles for detection of hepatocellular carcinoma marker glypican-3
por: Zhang, Qian-Yun, et al.
Publicado: (2011) -
A Chemiluminescent Immunoassay for Osteocalcin in Human Serum and a Solution to the “Hook Effect”
por: Han, Shuang, et al.
Publicado: (2020) -
Development of a Sensitive Chemiluminescence Immunoassay for the Quantification of Folic Acid in Human Serum
por: Chen, Xiang, et al.
Publicado: (2019)